This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
CPHI & PMEC India 2024 concluded successfully at the India Expo Centre in Greater Noida, Delhi-NCR, from November 26th to 28th. The three-day event brought together pharmaceutical innovations in machinery, analytical instruments, laboratory technologies, equipment, and ingredients. per cent to the nations GDP.
The 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26-28, 2024, at the India Expo Centre, Greater Noida, Delhi-NCR. India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030.
Leaders of the whole pharma value chain meet at PharmaceuticalManufacturing and Packaging Congress (PHARMAP) to find new connections and discuss trends of the industry. Rocco Paracchinin already registered as a speaker for PHARMAP 2024 and will talk about tech transfer goods and odds.
The event brought together over 330 professionals from across the industry’s value chain PharmaceuticalManufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.
The law was supposed to be fully enforced in late November, but the agency now says it will not take action until November 2024. At issue is the Drug Supply Chain Security Act, which has been implemented in steps over the past decade.
The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. It was designed to enhance the skills of pharmaceutical professionals and promote scientific excellence. The programme was led by S.
per cent from 2024 to 2030. PIC/S comprises 52 active member states and fosters cooperation between regulatory authorities and the pharmaceutical industry to promote GMP. This achievement supports the company’s expansion in new markets and enhances its ability to meet the global demand for enoxaparin.
Ahead of Bio 2024, we caught up with Matt Cokely, global technical consultant strategic leader, and Helen Gates, marketing director, at EcoLab Life Sciences to find out what the pharmaceuticalmanufacturing firm is planning for the event and how it is navigating current challenges in the industry.
These parks are critical in reducing India’s reliance on China and making the country an attractive location for pharmaceuticalmanufacturing. 2024, February 27). The Rise and Rise of the Pharmaceutical Supply Chain in India. Retrieved from [link] Califf, R. 2023, October 25). ” Retrieved from [link] Maersk.
CN Water participated in CPHI-PMEC, held in Noida from November 26 to 28, 2024, showcasing its water technology solutions under the theme “Purer, Safer, Greener Water.” The product aims to address energy efficiency challenges in the pharmaceuticalmanufacturing ecosystem. This initiative aligns with Industry 4.0
The post Environmental Monitoring In-Depth Focus 2024 appeared first on European Pharmaceutical Review. Register your details to access this exclusive content!
In March 2024, Lonza hosted its first digital Responsible Supplier Event which brought together more than 1,100 participants. As Lonza demonstrates, sustainable practices are not just environmental imperatives but essential components of modern pharmaceuticalmanufacturing.
The Indian Pharmaceutical Alliance (IPA) is set to host the ninth edition of the Global Pharmaceutical Quality Summit, on June 27 and 28, 2024 in Mumbai. The theme for this year’s Summit is ‘Advances in Manufacturing and Quality – Patient Centricity’.
The Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy announced the successful completion of the second session of the PULSE (Pharma Upgradation and Learning Series for Excellence) initiative, held on July 28, 2024. They also addressed data integrity, GDPR, and the need for change control in product manufacturing.
What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceuticalmanufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.
Between September and October 2024, EY-P and OPPI undertook primary research * consulting top CXOs from leading Indian and global multinational pharmaceutical companies, to understand their perspective on the pivotal growth areas for the Indian pharma industry. There should be transparency in all reporting.
Roche is working on the design of this modular facility and in this context also on the implementation of mobile robotics, which goes along with the need to have standardized interfaces that all mobile robot manufacturers can plug in to.
We intend to bring together people from the entire drug channel: pharmaceuticalmanufacturers, pharmacy benefit managers (PBMs), health plans, insurers, and plan sponsors, wholesalers and distributors, pharmacies, providers, buying groups, government officials, and more. We will also have a very limited number of sponsors.
The first industrial-scale pharmaceuticalmanufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. billion.
The day concluded with the prestigious India Pharma Awards 2024, celebrating outstanding achievements in innovation and excellence within the pharmaceutical industry.
This step is important as these countries are key markets for pharmaceuticalsmanufacturing. According to the Sustainable Markets Initiative, the agreements are set to bring around 70 megawatts (MW) of renewable power annually to the grid for global supply chains starting from 2024.
Rick explains why patients and pharmaceuticalmanufacturers now pay a greater share of prescription costs. He outlines GoodRx's services that address the twin challenges when the patient is the payer and the manufacturer faces intense gross-to-net pressures. Read on for Rick’s insights. All rights reserved.
On September 8, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 4 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative. It underscored the industry’s demand for learning about the Revised Schedule M and its impact on pharmaceuticalmanufacturing.
The Association of the British Pharmaceutical Industry (ABPI) and BioIndustry Association (BIA) both said that the increase acknowledges the enormous contribution made by the life sciences sector in helping to limit the impact of the pandemic through the rapid development of diagnostics, drugs and vaccines.
On October 6, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy conducted Session 6 of the PULSE (Pharma Upgradation & Learning Series for Excellence) initiative, focusing on HVAC Systems and Qualification in pharmaceuticalmanufacturing.
concluded that the advantages MM-IJ3DP for “in-batch manufacturing of different designs, combined with the controlled release of the active pharmaceutical ingredient (API) demonstrated here, offer realistic opportunities for advanced pharmaceuticsmanufacturing and personalised medicines”. Rivers et al.
On September 22, 2024, the Federation of Pharma Entrepreneurs (FOPE) and PharmaState Academy hosted Session 5 of the PULSE (Pharma Upgradation and Learning Series for Excellence) initiative, focusing on Water Systems and Qualification. Express Pharma serves as the Media Partner, with Trillyum Consulting as the Knowledge Partner.
FDA inspections Identification of data integrity deviations Of the 70 Warning Letters issued by the US Food and Drug Administration (FDA) so far in 2024, three have identified data integrity issues at pharmaceuticalmanufacturing sites outside the US. References Warning Letters. Internet} US FDA. cited2024Mar].
Current investors, including Atlantic Bridge, Uncork Capital and Crosslink Capital have also contributed to the funding, reaffirming their commitment to Aizon’s growth and the potential of AI in pharmaceuticalmanufacturing.
Health activists raise doubts on pharma associations self-monitoring the code The notification of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 on March 12 has been welcomed by major pharma associations, while health activists allege it is a “whitewash.”
On Dec 24, 2024, Bio-Thera Solutions Inc. announced that it has partnered with Tabuk PharmaceuticalManufacturing Company to commercialize BAT2206, a proposed ustekinumab biosimilar to Jansen’s STELARA, in Saudi Arabia. Also on December 24, 2024, GlycoNex, Inc.
The event, titled “New and Improved – AMCP Format for Formulary Submissions v5.0,” aims to educate pharmaceuticalmanufacturers and other healthcare stakeholders on the latest updates and best practices in dossier development. released in April 2024, marks the first update since 2020. The latest iteration, version 5.0,
The Prescription Drug Reform Act aims to regulate pharmacy benefit managers (PBMs) and pharmaceuticalmanufacturers in the state. The primary focus of this act is to bring transparency, accountability, and fairness to the outpatient pharmaceutical system in Florida, especially in relation to PBMs. Now, what is this act?
National Health Council Updates its Patient Engagement Fair-Market Value Calculator July 11, 2024 By: Omar A. This FMV Calculator has rates that are new as of March 2024. pharmaceuticalmanufacturers, academic centers, or other patient organizations). participation in an interview, focus group).
ICYMI, the FTC's report relied extensively on the Drug Channels Institute's (DCI's) 2024 Economic Report on U.S. Read more 2006-2024 HMP Omnimedia, LLC d/b/a Drug Channels Institute , an HMP Global Company. Pharmacies and Pharmacy Benefit Managers. Alas, patients remain caught in the drug channel's murky waters.
Earlier, The Tamil Nadu PharmaceuticalManufacturers Association (TN PMA), representing 150-odd micro and small drug manufacturing companies of that state, had made a similar request in a letter to the Union Health Minister and to the Drug Controller General of India (DCGI).
Revised Schedule M: A Complete Guide to Pharma Compliance Introduction Revised Schedule M is a critical update to Indias pharmaceuticalmanufacturing regulations. It aligns Good Manufacturing Practices (GMP) with international standards, ensuring quality, safety, and efficacy in drug production. What is Revised Schedule M?
BioNTech’s Singapore affiliate BioNTech Pharmaceuticals Asia Pacific has signed an agreement with Novartis Singapore PharmaceuticalManufacturing to acquire a GMP-certified manufacturing site in the country. . By 2024, the facility is anticipated to generate over 100 jobs in the country across a variety of fields.
The 17th edition of CPHI & PMEC India, organised by Informa Markets in India, will take place from 26th to 28th November 2024 at the India Expo Centre, Greater Noida, Delhi-NCR. The event will showcase developments in pharmaceutical modernisation, innovation, and sustainability.
Gaulkin — Enacted in 2022, the Inflation Reduction Act (IRA) amended the Medicare provisions of the Social Security Act to impose several discount requirements on pharmaceuticalmanufacturers. On July 31, 2024, CMS published a proposed rule to codify its guidances, with some changes.
300 crore, over the next two fiscal years (150 units each in 2024-25 and 2025-26). The intended beneficiaries are now specified as existing pharmaceuticalmanufacturing units with an average turnover of less than Rs. ” The revised scheme is expected to support 300 units, with a total outlay of Rs.
The expo enjoys support from key industry associations such as Bulk Drug Manufacturing Association (BDMA), Federation of Pharma Entrepreneurs (FOPE), Karnataka Drugs and PharmaceuticalsManufacturers’ Association (KDPMA), Organisation of Pharmaceutical Producers of India (OPPI), and Pharmaceutical Export Promotion Council (Pharmexcil).
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content